Skip to main content


Press Releases

November 14, 2017
GAITHERSBURG, Md., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has issued a Notice of Termination of Conversion Rights for all of its outstanding 2.875% Convertible Senior Notes due 2021 (“Notes”) and has elected to exercise its right to terminat...


Corporate Headquarters Ribbon Cutting

Lynn R. Kieffer 
TEL 240-631-3391 

Robert Burrows 
TEL 240-631-3280